Form 4 for EW Edwards Lifesciences
Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-08 · accession 0001225208-21-012146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-08 | 2021-09-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
| D | 2021-09-08 | 2021-09-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $121.25 | -6,350 | 98.0K | -6% | -$769.9K |
| D | 2021-09-08 | 2021-09-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $0.00 | -6,350 | 31.8K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-08 | M | A | 6,350 | $21.76 | 104,376.89 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-08 | S | D | 6,350 | $121.25 | 98,026.89 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $120.9900 to $121.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2021-09-08 | M | D | 6,350 | $0.00 | 31,750 | D | $21.76 · 2015-06-14 to 2022-05-13 | 6,350 Common Stock |